Annual revenue:
$28.75B+$1.64B(+6.04%)Summary
- As of today (April 15, 2025), GILD annual revenue is $28.75 billion, with the most recent change of +$1.64 billion (+6.04%) on December 31, 2024.
- During the last 3 years, GILD annual revenue has risen by +$1.45 billion (+5.31%).
- GILD annual revenue is now -11.90% below its all-time high of $32.64 billion, reached on December 31, 2015.
Performance
GILD Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$7.57B+$24.00M(+0.32%)Summary
- As of today (April 15, 2025), GILD quarterly revenue is $7.57 billion, with the most recent change of +$24.00 million (+0.32%) on December 31, 2024.
- Over the past year, GILD quarterly revenue has increased by +$24.00 million (+0.32%).
- GILD quarterly revenue is now -11.02% below its all-time high of $8.51 billion, reached on December 31, 2015.
Performance
GILD Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$28.75B+$455.00M(+1.61%)Summary
- As of today (April 15, 2025), GILD TTM revenue is $28.75 billion, with the most recent change of +$455.00 million (+1.61%) on December 31, 2024.
- Over the past year, GILD TTM revenue has increased by +$455.00 million (+1.61%).
- GILD TTM revenue is now -12.44% below its all-time high of $32.84 billion, reached on March 31, 2016.
Performance
GILD TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GILD Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.0% | +0.3% | +1.6% |
| 3 y3 years | +5.3% | +0.3% | +1.6% |
| 5 y5 years | +28.1% | +0.3% | +1.6% |
GILD Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.0% | at high | +20.9% | at high | +6.3% |
| 5 y | 5-year | at high | +28.1% | at high | +47.2% | at high | +29.7% |
| alltime | all time | -11.9% | >+9999.0% | -11.0% | >+9999.0% | -12.4% | >+9999.0% |
Gilead Sciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $28.75B(+6.0%) | $7.57B(+0.3%) | $28.75B(+1.6%) |
| Sep 2024 | - | $7.54B(+8.5%) | $28.30B(+1.8%) |
| Jun 2024 | - | $6.95B(+4.0%) | $27.80B(+1.3%) |
| Mar 2024 | - | $6.69B(-6.0%) | $27.45B(+1.2%) |
| Dec 2023 | $27.12B(-0.6%) | $7.11B(+0.9%) | $27.11B(-1.0%) |
| Sep 2023 | - | $7.05B(+6.8%) | $27.39B(+0.0%) |
| Jun 2023 | - | $6.60B(+3.9%) | $27.38B(+1.3%) |
| Mar 2023 | - | $6.35B(-14.0%) | $27.04B(-0.9%) |
| Dec 2022 | $27.28B(-0.1%) | $7.39B(+4.9%) | $27.28B(+0.5%) |
| Sep 2022 | - | $7.04B(+12.5%) | $27.14B(-1.4%) |
| Jun 2022 | - | $6.26B(-5.0%) | $27.52B(+0.2%) |
| Mar 2022 | - | $6.59B(-9.0%) | $27.47B(+0.6%) |
| Dec 2021 | $27.30B(+10.6%) | $7.24B(-2.4%) | $27.30B(-0.6%) |
| Sep 2021 | - | $7.42B(+19.4%) | $27.48B(+3.2%) |
| Jun 2021 | - | $6.22B(-3.2%) | $26.64B(+4.2%) |
| Mar 2021 | - | $6.42B(-13.4%) | $25.56B(+3.5%) |
| Dec 2020 | $24.69B(+10.0%) | $7.42B(+12.8%) | $24.69B(+6.7%) |
| Sep 2020 | - | $6.58B(+27.9%) | $23.15B(+4.4%) |
| Jun 2020 | - | $5.14B(-7.3%) | $22.17B(-2.4%) |
| Mar 2020 | - | $5.55B(-5.6%) | $22.72B(+1.2%) |
| Dec 2019 | $22.45B(+1.5%) | $5.88B(+4.9%) | $22.45B(+0.4%) |
| Sep 2019 | - | $5.60B(-1.4%) | $22.36B(+0.0%) |
| Jun 2019 | - | $5.68B(+7.7%) | $22.36B(+0.2%) |
| Mar 2019 | - | $5.28B(-8.9%) | $22.32B(+0.9%) |
| Dec 2018 | $22.13B(-15.2%) | $5.79B(+3.6%) | $22.13B(-0.7%) |
| Sep 2018 | - | $5.60B(-0.9%) | $22.28B(-3.9%) |
| Jun 2018 | - | $5.65B(+11.0%) | $23.20B(-6.0%) |
| Mar 2018 | - | $5.09B(-14.5%) | $24.69B(-5.4%) |
| Dec 2017 | $26.11B(-14.1%) | $5.95B(-8.6%) | $26.11B(-5.0%) |
| Sep 2017 | - | $6.51B(-8.8%) | $27.48B(-3.5%) |
| Jun 2017 | - | $7.14B(+9.8%) | $28.47B(-2.2%) |
| Mar 2017 | - | $6.50B(-11.1%) | $29.10B(-4.2%) |
| Dec 2016 | $30.39B(-6.9%) | $7.32B(-2.4%) | $30.39B(-3.8%) |
| Sep 2016 | - | $7.50B(-3.5%) | $31.58B(-2.5%) |
| Jun 2016 | - | $7.78B(-0.2%) | $32.37B(-1.4%) |
| Mar 2016 | - | $7.79B(-8.4%) | $32.84B(+0.6%) |
| Dec 2015 | $32.64B(+31.1%) | $8.51B(+2.5%) | $32.64B(+3.8%) |
| Sep 2015 | - | $8.29B(+0.6%) | $31.45B(+7.7%) |
| Jun 2015 | - | $8.24B(+8.6%) | $29.19B(+6.2%) |
| Mar 2015 | - | $7.59B(+3.8%) | $27.48B(+10.4%) |
| Dec 2014 | $24.89B(+122.2%) | $7.31B(+21.1%) | $24.89B(+20.3%) |
| Sep 2014 | - | $6.04B(-7.5%) | $20.70B(+18.7%) |
| Jun 2014 | - | $6.54B(+30.7%) | $17.44B(+27.6%) |
| Mar 2014 | - | $5.00B(+60.2%) | $13.67B(+22.0%) |
| Dec 2013 | $11.20B(+15.5%) | $3.12B(+12.1%) | $11.20B(+5.0%) |
| Sep 2013 | - | $2.78B(+0.6%) | $10.67B(+3.5%) |
| Jun 2013 | - | $2.77B(+9.3%) | $10.31B(+3.6%) |
| Mar 2013 | - | $2.53B(-2.2%) | $9.95B(+2.6%) |
| Dec 2012 | $9.70B(+15.7%) | $2.59B(+6.6%) | $9.70B(+4.2%) |
| Sep 2012 | - | $2.43B(+0.9%) | $9.31B(+3.4%) |
| Jun 2012 | - | $2.41B(+5.4%) | $9.01B(+3.1%) |
| Mar 2012 | - | $2.28B(+3.7%) | $8.74B(+4.2%) |
| Dec 2011 | $8.39B(+5.5%) | $2.20B(+3.7%) | $8.39B(+2.5%) |
| Sep 2011 | - | $2.12B(-0.7%) | $8.18B(+2.3%) |
| Jun 2011 | - | $2.14B(+11.0%) | $8.00B(+2.7%) |
| Mar 2011 | - | $1.93B(-3.6%) | $7.79B(-2.0%) |
| Dec 2010 | $7.95B(+13.4%) | $2.00B(+3.1%) | $7.95B(-0.4%) |
| Sep 2010 | - | $1.94B(+0.5%) | $7.98B(+1.7%) |
| Jun 2010 | - | $1.93B(-7.6%) | $7.85B(+3.7%) |
| Mar 2010 | - | $2.09B(+2.6%) | $7.57B(+7.9%) |
| Dec 2009 | $7.01B(+31.4%) | $2.03B(+12.8%) | $7.01B(+9.4%) |
| Sep 2009 | - | $1.80B(+9.4%) | $6.41B(+7.2%) |
| Jun 2009 | - | $1.65B(+7.6%) | $5.98B(+6.6%) |
| Mar 2009 | - | $1.53B(+7.2%) | $5.61B(+5.1%) |
| Dec 2008 | $5.34B(+26.1%) | $1.43B(+4.2%) | $5.34B(+6.7%) |
| Sep 2008 | - | $1.37B(+7.3%) | $5.00B(+6.7%) |
| Jun 2008 | - | $1.28B(+1.6%) | $4.69B(+5.2%) |
| Mar 2008 | - | $1.26B(+14.9%) | $4.46B(+5.4%) |
| Dec 2007 | $4.23B | $1.09B(+3.4%) | $4.23B(+4.8%) |
| Sep 2007 | - | $1.06B(+1.0%) | $4.03B(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $1.05B(+1.9%) | $3.72B(+10.8%) |
| Mar 2007 | - | $1.03B(+14.4%) | $3.36B(+11.1%) |
| Dec 2006 | $3.03B(+49.2%) | $899.23M(+20.1%) | $3.03B(+10.6%) |
| Sep 2006 | - | $748.73M(+9.3%) | $2.74B(+10.3%) |
| Jun 2006 | - | $685.30M(-1.1%) | $2.48B(+8.3%) |
| Mar 2006 | - | $692.88M(+13.7%) | $2.29B(+12.9%) |
| Dec 2005 | $2.03B(+53.1%) | $609.27M(+23.5%) | $2.03B(+13.4%) |
| Sep 2005 | - | $493.45M(-0.4%) | $1.79B(+10.3%) |
| Jun 2005 | - | $495.27M(+15.1%) | $1.62B(+12.1%) |
| Mar 2005 | - | $430.41M(+16.5%) | $1.45B(+9.2%) |
| Dec 2004 | $1.32B(+52.6%) | $369.58M(+13.3%) | $1.32B(+8.7%) |
| Sep 2004 | - | $326.19M(+2.0%) | $1.22B(+11.5%) |
| Jun 2004 | - | $319.72M(+3.4%) | $1.09B(+8.0%) |
| Mar 2004 | - | $309.13M(+17.3%) | $1.01B(+16.6%) |
| Dec 2003 | $867.86M(+85.9%) | $263.52M(+31.5%) | $867.86M(+15.8%) |
| Sep 2003 | - | $200.37M(-16.1%) | $749.37M(+9.7%) |
| Jun 2003 | - | $238.87M(+44.7%) | $682.99M(+23.4%) |
| Mar 2003 | - | $165.10M(+13.8%) | $553.48M(+18.6%) |
| Dec 2002 | $466.79M(+99.7%) | $145.03M(+8.2%) | $466.79M(+17.8%) |
| Sep 2002 | - | $133.98M(+22.5%) | $396.09M(+26.5%) |
| Jun 2002 | - | $109.36M(+39.5%) | $313.02M(+23.1%) |
| Mar 2002 | - | $78.42M(+5.5%) | $254.35M(+8.8%) |
| Dec 2001 | $233.77M(+19.5%) | $74.33M(+46.0%) | $233.77M(+8.9%) |
| Sep 2001 | - | $50.91M(+0.4%) | $214.70M(+2.8%) |
| Jun 2001 | - | $50.69M(-12.4%) | $208.88M(+0.3%) |
| Mar 2001 | - | $57.84M(+4.7%) | $208.32M(+5.1%) |
| Dec 2000 | $195.56M(+15.7%) | $55.27M(+22.6%) | $198.19M(+3.4%) |
| Sep 2000 | - | $45.09M(-10.1%) | $191.73M(+3.6%) |
| Jun 2000 | - | $50.13M(+5.1%) | $185.04M(+3.7%) |
| Mar 2000 | - | $47.71M(-2.2%) | $178.45M(+5.6%) |
| Dec 1999 | $169.00M(+11.8%) | $48.80M(+27.1%) | $169.01M(+3.9%) |
| Sep 1999 | - | $38.40M(-11.8%) | $162.61M(+4.2%) |
| Jun 1999 | - | $43.54M(+13.7%) | $156.11M(+30.6%) |
| Mar 1999 | - | $38.28M(-9.7%) | $119.58M(+26.0%) |
| Dec 1998 | $151.10M(+14.2%) | $42.40M(+32.9%) | $94.90M(-38.7%) |
| Sep 1998 | - | $31.90M(+355.7%) | $154.70M(+21.1%) |
| Jun 1998 | - | $7.00M(-48.5%) | $127.70M(-9.0%) |
| Mar 1998 | - | $13.60M(-86.7%) | $140.40M(+6.1%) |
| Dec 1997 | $132.30M(+296.1%) | $102.20M(+1985.7%) | $132.30M(+268.5%) |
| Sep 1997 | - | $4.90M(-75.1%) | $35.90M(-35.5%) |
| Jun 1997 | - | $19.70M(+258.2%) | $55.70M(+45.8%) |
| Mar 1997 | - | $5.50M(-5.2%) | $38.20M(+14.0%) |
| Dec 1996 | $33.40M(+1137.0%) | $5.80M(-76.5%) | $33.50M(+20.9%) |
| Sep 1996 | - | $24.70M(+1022.7%) | $27.70M(+575.6%) |
| Jun 1996 | - | $2.20M(+175.0%) | $4.10M(+46.4%) |
| Mar 1996 | - | $800.00K(-27.3%) | $2.80M(-33.3%) |
| Dec 1995 | $2.70M(-44.9%) | - | - |
| Sep 1995 | - | $1.10M(+22.2%) | $4.20M(-10.6%) |
| Jun 1995 | - | $900.00K(0.0%) | $4.70M(-4.1%) |
| Mar 1995 | - | $900.00K(-30.8%) | $4.90M(-3.9%) |
| Mar 1995 | $4.90M(+19.5%) | - | - |
| Dec 1994 | - | $1.30M(-18.8%) | $5.10M(+4.1%) |
| Sep 1994 | - | $1.60M(+45.5%) | $4.90M(+14.0%) |
| Jun 1994 | - | $1.10M(0.0%) | $4.30M(+2.4%) |
| Mar 1994 | $4.10M(-2.4%) | $1.10M(0.0%) | $4.20M(+2.4%) |
| Dec 1993 | - | $1.10M(+10.0%) | $4.10M(+2.5%) |
| Sep 1993 | - | $1.00M(0.0%) | $4.00M(0.0%) |
| Jun 1993 | - | $1.00M(0.0%) | $4.00M(-2.4%) |
| Mar 1993 | $4.20M(+50.0%) | $1.00M(0.0%) | $4.10M(-18.0%) |
| Dec 1992 | - | $1.00M(0.0%) | $5.00M(+11.1%) |
| Sep 1992 | - | $1.00M(-9.1%) | $4.50M(+21.6%) |
| Jun 1992 | - | $1.10M(-42.1%) | $3.70M(+32.1%) |
| Mar 1992 | $2.80M(+115.4%) | $1.90M(+280.0%) | $2.80M(+33.3%) |
| Dec 1991 | - | $500.00K(+150.0%) | $2.10M(+23.5%) |
| Sep 1991 | - | $200.00K(0.0%) | $1.70M(+6.3%) |
| Jun 1991 | - | $200.00K(-83.3%) | $1.60M(+6.7%) |
| Mar 1991 | $1.30M | $1.20M(+1100.0%) | $1.50M(+400.0%) |
| Dec 1990 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Sep 1990 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Jun 1990 | - | $100.00K | $100.00K |
FAQ
- What is Gilead Sciences annual revenue?
- What is the all time high annual revenue for Gilead Sciences?
- What is Gilead Sciences annual revenue year-on-year change?
- What is Gilead Sciences quarterly revenue?
- What is the all time high quarterly revenue for Gilead Sciences?
- What is Gilead Sciences quarterly revenue year-on-year change?
- What is Gilead Sciences TTM revenue?
- What is the all time high TTM revenue for Gilead Sciences?
- What is Gilead Sciences TTM revenue year-on-year change?
What is Gilead Sciences annual revenue?
The current annual revenue of GILD is $28.75B
What is the all time high annual revenue for Gilead Sciences?
Gilead Sciences all-time high annual revenue is $32.64B
What is Gilead Sciences annual revenue year-on-year change?
Over the past year, GILD annual revenue has changed by +$1.64B (+6.04%)
What is Gilead Sciences quarterly revenue?
The current quarterly revenue of GILD is $7.57B
What is the all time high quarterly revenue for Gilead Sciences?
Gilead Sciences all-time high quarterly revenue is $8.51B
What is Gilead Sciences quarterly revenue year-on-year change?
Over the past year, GILD quarterly revenue has changed by +$24.00M (+0.32%)
What is Gilead Sciences TTM revenue?
The current TTM revenue of GILD is $28.75B
What is the all time high TTM revenue for Gilead Sciences?
Gilead Sciences all-time high TTM revenue is $32.84B
What is Gilead Sciences TTM revenue year-on-year change?
Over the past year, GILD TTM revenue has changed by +$455.00M (+1.61%)